Vidaza
(Азацитидин)
(100mg)
(one)
(Bottle)
Vidaza (azacitidine) 100 мг, India
In Stock
Indications for Vidaza
Treatment of adult patients who cannot undergo hematopoietic stem cell transplantation:
myelodysplastic syndrome (MDS) with high or intermediate-2 risk according to the IPSS scale (International Prognostic Scoring System);
acute myeloid leukemia;
chronic myelomonocytic leukemia without signs of MDS.
-
Commercial name:Vidaza
-
Сhemical name:Азацитидин
-
Dosage:100mg
-
Quantity:one
-
Release form:Bottle
-
Виробник:Индия
No reviews yet